Send us Feedback

Clorox Company (CLX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

 
Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (May 17, 2013)
  • 8-K (May 1, 2013)
  • 8-K (Feb 4, 2013)
  • 8-K (Jan 25, 2013)
  • 8-K (Nov 16, 2012)
  • 8-K (Oct 31, 2012)

 
Other

Clorox Company 8-K 2008

Documents found in this filing:

  1. 8-K/A
  2. Ex-23.1
  3. Ex-99.1
  4. Ex-99.2
  5. Ex-99.3
  6. Graphic
  7. Graphic
  8. Graphic
  9. Graphic
Form 8-K/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): November 30, 2007

 

 

THE CLOROX COMPANY

(Exact Name of Registrant as Specified in its Charter)

 

 

 

 

Delaware   1-07151   31-0595760

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

1221 Broadway, Oakland, California 94612-1888

(Address of Principal Executive Offices) (Zip Code)

(510) 271-7000

(Registrant’s Telephone Number, including Area Code)

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

ITEM 2.01.     COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

This Amendment No. 1 amends the Current Report on Form 8-K filed by The Clorox Company (the “Company”) on December 3, 2007 (the “December 8-K”) related to the Company’s acquisition of Burt’s Bees Inc. (“BBI”). This Form 8-K/A amends the December 8-K to include the financial information required under Item 9.01. The information previously reported in the December 8-K is hereby incorporated by reference into this Form 8-K/A.

 

ITEM 9.01.     FINANCIAL STATEMENTS AND EXHIBITS.

 

(a) Financial statements of business acquired.

The audited Consolidated Financial Statements of BBI as of and for the years ended December 31, 2006 and 2005 are attached hereto as Exhibit 99.1 and are incorporated herein by reference. The unaudited financial statements for BBI’S interim periods ended September 30, 2007 and 2006 are attached hereto as Exhibit 99.2 and are incorporated herein by reference.

 

(b) Pro forma financial information.

 

  (i) Unaudited Pro Forma Condensed Combined Statement of Earnings for the year ended June 30, 2007.

 

  (ii) Unaudited Pro Forma Condensed Combined Statement of Earnings for the three months ended September 30, 2007.

 

  (iii) Unaudited Pro Forma Condensed Combined Balance Sheet as of September 30, 2007.

 

  (iv) Notes to the Unaudited Pro Forma Condensed Combined Financial Statements.

 

(c) Not applicable.

 

(d) Exhibits.

 

EXHIBIT NO.

   

DESCRIPTION

23.1    Consent of Independent Registered Public Accounting Firm
99.1    Consolidated Financial Statements of BBI as of and for the years ended December 31, 2006 and 2005
99.2    Unaudited Condensed Consolidated Financial Statements of BBI as of and for the nine months ended September 30, 2007 and 2006
99.3    Unaudited Pro Forma Condensed Combined Financial Statements

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    The Clorox Company
Date: February 12, 2008     By:   /s/ Laura Stein
      Laura Stein
      Senior Vice President – General Counsel

 

3

EXHIBIT INDEX

 

EXHIBIT NO.

   

DESCRIPTION

23.1    Consent of Independent Registered Public Accounting Firm
99.1    Consolidated Financial Statements of BBI as of and for the years ended December 31, 2006 and 2005
99.2    Unaudited Condensed Consolidated Financial Statements of BBI as of and for the nine months ended September 30, 2007 and 2006
99.3    Unaudited Pro Forma Condensed Combined Financial Statements

 

4

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki